Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Journal
Overview
publication venue for
Design and creation of a racially diverse lung cancer registry with detailed genomic and environmental annotation.
2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer. .
34.
2025
Variation in prostate-specific antigen levels by age, adiposity, race and ethnicity, and genetic risk: Implications for prostate cancer screening.
2025
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort. .
33.
2024
Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study. .
33.
2024
Lung microbial and host genomic signatures as predictors of prognosis in early-stage adenocarcinoma.
2024
Associations between etiologic or prognostic tumor tissue markers and neighborhood contextual factors in male health professionals diagnosed with prostate cancer.
2023
Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Advanced Colorectal Cancer. .
31.
2022
The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study. .
31.
2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.
2022
Plasma Metabolomics and Breast Cancer Risk over 20 Years of Follow-up among Postmenopausal Women in the Nurses' Health Study. .
31.
2022
Regular Aspirin Use and Mortality in Multiple Myeloma Patients.
2021
A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk. .
31.
2021
Ovarian Cancer Risk in Relation to Blood Cholesterol and Triglycerides. .
30.
2021
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes. .
30.
2021
Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer. .
30.
2021
Low Subcutaneous Adiposity and Mortality in Esophageal Cancer. .
30.
2020
Risk of Breast Cancer Associated with Estrogen DNA Adduct Biomarker. .
29.
2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma. .
29.
2020
Prediagnostic 25-Hydroxyvitamin D Concentrations in Relation to Tumor Molecular Alterations and Risk of Breast Cancer Recurrence. .
29.
2020
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk. .
29.
2020
Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians. .
29.
2019
A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer. .
28.
2019
Targeted Cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers. .
28.
2019
Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents. .
28.
2019
Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer. .
28.
2018
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. .
28.
2018
A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status. .
27.
2018
Height, Obesity, and the Risk of TMPRSS2:ERG -Defined Prostate Cancer. .
27.
2017
MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer. .
27.
2017
Vasectomy and Risk of Prostate Cancer in a Screening Trial. .
26.
2017
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions. .
25.
2016
Clinicopathologic Features of Colorectal Carcinoma in HIV-Positive Patients. .
25.
2016
Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes. .
25.
2016
Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid. .
24.
2015
Trajectories of depressive symptoms following breast cancer diagnosis. .
24.
2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. .
24.
2015
Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study. .
24.
2015
Association of prostate cancer risk variants with gene expression in normal and tumor tissue. .
24.
2014
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer. .
23.
2014
Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. .
23.
2014
Cancer screening and genetics: a tale of two paradigms. .
23.
2014
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment. .
23.
2014
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. .
22.
2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. .
22.
2013
Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. .
22.
2013
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. .
21.
2012
Insulin therapy and colorectal adenomas in patients with diabetes mellitus. .
21.
2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. .
21.
2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. .
21.
2012
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). .
21.
2011
Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. .
21.
2011
FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. .
20.
2011
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. .
20.
2011
MET expression and amplification in patients with localized gastric cancer. .
20.
2011
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening. .
20.
2010
Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007. .
20.
2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma. .
19.
2010
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. .
19.
2010
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. .
19.
2010
Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening. .
19.
2010
Risk of meningioma and common variation in genes related to innate immunity. .
19.
2010
Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study. .
19.
2010
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. .
19.
2010
Smoking cessation and relapse during a lung cancer screening program. .
18.
2009
Common variation in genes related to innate immunity and risk of adult glioma. .
18.
2009
Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. .
18.
2009
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. .
17.
2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. .
17.
2008
A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas. .
17.
2008
Cigarette smoking and risk of lung metastasis from esophageal cancer. .
17.
2008
Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. .
17.
2008
Effects of socioeconomic status and treatment disparities in colorectal cancer survival. .
17.
2008
A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study. .
17.
2008
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. .
16.
2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. .
16.
2007
Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. .
16.
2007
Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. .
16.
2007
Lead, genetic susceptibility, and risk of adult brain tumors. .
15.
2006
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. .
15.
2006
Tobacco use in adult long-term survivors of retinoblastoma. .
15.
2006
Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma. .
15.
2006
RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. .
15.
2006
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. .
15.
2006
A comparison of bilateral breast cancers in BRCA carriers. .
14.
2005
Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. .
14.
2005
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. .
14.
2005
Influence of type of cigarette on peripheral versus central lung cancer. .
14.
2005
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer. .
14.
2005
Diet and melanoma in a case-control study. .
13.
2004
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. .
13.
2004
Cancer in first-degree relatives and risk of glioma in adults. .
12.
2003
The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. .
12.
2003
Handedness and risk of brain tumors in adults. .
12.
2003
Polio vaccination and risk of brain tumors in adults: no apparent association. .
12.
2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. .
12.
2003
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. .
12.
2003
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. .
11.
2002
P gene as an inherited biomarker of human eye color. .
11.
2002
Oral cancer risk perception among participants in an oral cancer screening program. .
11.
2002
Inverse associations between plasma lycopene and other carotenoids and prostate cancer. .
10.
2001
Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. .
10.
2001
GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. .
9.
2000
Evaluation of factors associated with skin self-examination. .
8.
1999
Cigarette smoking and chromosome 9 alterations in bladder cancer. .
6.
1997
p53 mutations and occupational exposures in a surgical series of lung cancers. .
5.
1996
Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. .
5.
1996
Simian virus 40 and pleural mesothelioma in humans. .
5.
1996
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. .
4.
1995
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. .
3.
1994
Prostitution, HIV, and cervical neoplasia: a survey in Spain and Colombia. .
2.
1993
The Honest Broker: Reimagining the Roles of Health Services Research, Community Partnership, and Policymaking to Address Structural Determinants of Cancer Outcomes. .
34.
2025
Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors.
2014
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers.
2016
Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.
2009
Identity
ISO Abbreviation
Cancer Epidemiol Biomarkers Prev
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
